MiniMed Announces Board of Directors for its Next Chapter as an Independent Company
MiniMed announced its nine-member Board of Directors following completion of its separation from Medtronic and Nasdaq listing in March 2026. Amy Bricker (Walgreens/Express Scripts) and Tim L. Main (former Jabil CEO) join effective immediately as part of the planned transition from Medtronic-designated directors; Kevin E. Lofton remains chair.
Key figures
- Board size
- 9
- New directors added
- 2
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.